专题:Neurological Disorders and Treatments

This cluster of papers focuses on the investigation of neuroprotective agents such as Citicoline and Cerebrolysin in the context of oxidative stress, ischemic stroke, brain injury, glaucoma, and neurodegenerative diseases like Alzheimer's. The research explores their mechanisms of action, effects on mitochondrial dysfunction, neuroprotection, and potential for promoting neuroregeneration.
最新文献
ABSTRACT NUMBER: ESOC2026A632 CYTOPROTECTIVE EFFICACY OF CEREBROLYSIN IN PATIENTS WITH RESIDUAL POST-THROMBECTOMY PERFUSION DEFICITS: A PROOF-OF-CONCEPT STUDY

article Full Text OpenAlex

Asundexian for Secondary Stroke Prevention

article Full Text OpenAlex

Fortelyzin in the treatment of acute ischemic stroke in patients ≥80 years old: data from the observational study FORPI registry

article Full Text OpenAlex

Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease

article Full Text OpenAlex

Hypolipidemics reduce the rate of Alzheimer's disease development and dementia progression: A cohort study linked with genetic and neuropathological analyses

article Full Text OpenAlex

Specificity of verbal description of pain by patients with cognitive disorders with vascular genesis

article Full Text OpenAlex

Lipid peroxidation as a driver of oxidative and neuroinflammatory damage in ocular disease: review and perspectives

article Full Text OpenAlex

Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial

article Full Text OpenAlex

Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry

article Full Text OpenAlex

The efficacy and safety of intra-arterial tenecteplase after recanalization in ischemic stroke: A systematic review and meta-analysis with trial sequential analysis and GRADE assessment

article Full Text OpenAlex

近5年高被引文献
Role of Cholinergic Signaling in Alzheimer’s Disease

review Full Text OpenAlex 758 FWCI117.2217

Alzheimer’s Disease: Epidemiology and Clinical Progression

review Full Text OpenAlex 526 FWCI71.1582

Neurotransmitters—Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System

review Full Text OpenAlex 522 FWCI45.7743

Alzheimer's disease drug development pipeline: 2023

review Full Text OpenAlex 452 FWCI62.5987

Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta-analysis and systematic review of epidemiology studies.

review Full Text OpenAlex 381 FWCI50.0635

Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment

review Full Text OpenAlex 261 FWCI19.4012

Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022

article Full Text OpenAlex 234 FWCI27.8338

Japan Stroke Society Guideline 2021 for the Treatment of Stroke

article Full Text OpenAlex 222 FWCI31.357

Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives

review Full Text OpenAlex 213 FWCI22.7795

New perspectives in diabetic neuropathy

review Full Text OpenAlex 205 FWCI35.7519